Phase 2 Mania Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Bipolar I DisorderMania
Neurocrine Biosciences150 enrolled6 locationsNCT07288320
Recruiting
Phase 2
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
Trichotillomania (Hair-Pulling Disorder)
Yale University20 enrolled1 locationNCT05207085
Recruiting
Phase 2
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Cutaneous Leishmaniasis
Al-Mustafa University College80 enrolled1 locationNCT06798402
Recruiting
Phase 2
Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Hayder Adnan Fawzi40 enrolled1 locationNCT06797544
Recruiting
Phase 2
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine
Mucosal Leishmaniasis
Fundacion Nacional de Dermatologia30 enrolled1 locationNCT06550609
Recruiting
Phase 2
Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
Hayder Adnan Fawzi40 enrolled1 locationNCT06798415
Recruiting
Phase 2Phase 3
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Leishmaniasis, MucocutaneousLeishmaniasis; Brazilian
University of Brasilia100 enrolled1 locationNCT06040489
Completed
Phase 2Phase 3
Liposomal amphotericin B for the treatment of Nepalese patients with visceral leishmaniasis.
Visceral Leishmaniasis
The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35 enrolled1 locationACTRN12610000130066
Active
Phase 2Phase 3
Liposomal amphotericin B for the treatment of Bangladeshi patients with visceral leishmaniasis.
Visceral leishmaniasis (VL)
The United Nations Children's Fund (UNICEF)/ The United Nations Development Programme (UNDP) /World Bank /World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)35 enrolled1 locationACTRN12609001029280